News

31. Novotech Releases In-Depth Report On Cervical Cancer: Addressing A Global Health Challenge 12/4/2024

    Boston, USA – Novotech, the global full-service clinical Contract Research Organization (CRO), has released a new report, Cervical Cancer - Global Clinical Trial Landscape. This report offers a comprehensive analysis of the global cervical cancer research landscape, highlighting the crucial role of clinical trials in advancing treatment options. It outlines key geographic trends, emerging therapies, and future projections, providing valuable insights for researchers and healthcare professionals working to combat this disease.

32. Novotech And Biostar Establish Strategic Partnership Following Biostar's HKEX Listing 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has announced a long-term strategic partnership with Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK) (“Biostar”). This collaboration strengthens the commitment of both companies to advance clinical research, leveraging Novotech’s expertise and technical platforms to support Biostar’s clinical development plans. 

33. Show Chwan Health Care System Joins Hands With Novotech To Accelerate The Quality Of International Clinical Trials Of New Drugs 12/4/2024

    Show Chwan Health Care System announced that it has signed a Memorandum of Understanding (MOU) with Novotech, a clinical research organization (CRO) in the Asia-Pacific region. It will use Novotech’s experience in planning clinical trials to target Changhua and the introduction of new clinical trial cases in Tainan, which will help doctors and patients get in touch with the latest treatment technologies and shorten the development period of new drugs.

34. Avance Clinical Wins Premier's Business And Export Awards 2024 11/26/2024

    Avance Clinical is thrilled to announce that it has again been named as a winner in the prestigious South Australian Premier’s Business and Export Awards 2024. This honor underscores Avance Clinical’s continued commitment to driving innovation and delivering world-class clinical trial solutions to the global market, and comes on the heels of winning the 2023 International Health Exporter of the Year at last year’s awards ceremony. 

35. Avance Clinical Recognized As Finalist In 62nd Australian Export Awards For International Health 11/26/2024

    Avance Clinical, a leading Australian Contract Research Organization (CRO), has been named a finalist in the prestigious 62nd Australian Export Awards, under the International Health category. This recognition highlights the company’s exceptional contributions to the global biotechnology sector, supported by its reputation for delivering high-quality data, fast clinical trial timelines, and innovative clinical trial solutions.

36. ProductLife Group (PLG) Acquires Halloran To Further Expand Its Global Reach And Capabilities To Support The Development Of New Therapies 11/22/2024

    BOSTON; Oct. 16, 2024 (Business Wire) – ProductLife Group (PLG), a trusted global leader in regulatory, scientific, compliance, and digital transformation consulting services for the life sciences, today announced the acquisition of Halloran Consulting Group, a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support in the pharmaceutical, biotechnology, and medical device sectors in the United States, further positioning PLG as a leading global provider of comprehensive healthcare services.

37. Medable And Google Join Forces To Deliver Digital Trials 11/21/2024

    Discover brand-new cutting-edge Google Cloud infrastructure and AI capabilities with the newly launched Medable Studio, a unique SaaS solution that provides pharmaceutical companies control and transparency in clinical trial design, deployment, and management. 

38. Medable AI Simplifies Trial Launch With Instant eCOA Generation 11/21/2024

    See the impact of AI’s new capabilities, such as automatically converting existing outcomes assessments into fully digital eCOAs in seconds and instantly generating scale assessments of varying complexity and logic.

39. PCI Pharma Services And ChiRhoClin Partner To Prevent Shortage Of Critical Orphan Pancreatic Drug 11/19/2024

    PCI Pharma Services – (“PCI”) a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies – is collaborating with theranostics specialist ChiRhoClin, Inc. to avoid the potential shortage of a critical diagnostic drug used to test for pancreatic disease and cancer. Following a high-priority

40. Leading The Way: OpenClinica EDC Earns Major Recognition 11/18/2024